NextCell Pharma
3,32
SEK
-4,05 %
Mindre end 1K følgere
NXTCL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
-4,05%
-1,19%
+16,9%
+64,36%
+125,85%
+42%
-38,64%
-3,58%
+50,13%
NextCell Pharma operates in the healthcare sector. Today, development is carried out of stem cell products mainly used in the treatment of autoimmune diabetes and for kidney transplants. A significant part of the work consists of stem cell research where the company develops drug candidates that should enable and increase the acceptance of organ transplants. In addition, the company has a stem cell bank. The company was established in 2014 and is based in Huddinge.
Læs mereMarkedsværdi
242,66 mio. SEK
Aktieomsætning
1,43 mio. SEK
Omsætning
10,66 mio.
EBIT %
-404,97 %
P/E
-
Udbytteafkast, %
-
Finanskalender
25.4
2025
Delårsrapport Q2'25
24.7
2025
Delårsrapport Q3'25
30.10
2025
Årsrapport '25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
NextCell Pharma AB: All Patients with Severe Virus-Induced Pneumonia Treated in the ProTrans V Study
Redeye: Redeye Initiates Coverage of NextCell Pharma
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools